KRN7000 applied to AIDS research

Technical Advance: Measurement of iNKT cell responses at the single-cell level against rare HIV-1-infected dendritic cells in a mixed culture

Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens

Enhancement of HIV DNA vaccine immunogenicity by the NKT cell ligand, alpha-galactosylceramide

Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells.

CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection

Adjuvant Effects of an NKT Ligand, alpha-Galactosylceramide, on DNA Vaccination






New 7DW8-5 glycolipid


Now available 7DW8-5 glycolipid derivative of Alpha-GalCer for human and mice iNKT immunoresearch


Meet Funakoshi Company
at the following meetings:

NIH Research Festival
Bethesda, MD
September 13-14, 2018

San Diego, CA
December 8-12